Big Punches Come in Nanosizes for Chemoprevention
暂无分享,去创建一个
[1] S. Sukumar,et al. Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: Implications for breast cancer chemoprevention in at-risk populations. , 2012, Carcinogenesis.
[2] B. Rigas,et al. Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives. , 2012, Nanomedicine.
[3] Ying Huang,et al. Chemoprevention of Colon Cancer in a Rat Carcinogenesis Model Using a Novel Nanotechnology-Based Combined Treatment System , 2011, Cancer Prevention Research.
[4] Jeffrey R. Wang,et al. A Novel Combinatorial Nanotechnology-Based Oral Chemopreventive Regimen Demonstrates Significant Suppression of Pancreatic Cancer Neoplastic Lesions , 2013, Cancer Prevention Research.
[5] R. Parhi,et al. Preparation and characterization of solid lipid nanoparticles-a review. , 2012, Current drug discovery technologies.
[6] Shivendra V. Singh,et al. Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research. , 2012, Carcinogenesis.
[7] S. Mousa,et al. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. , 2009, Cancer research.
[8] S. Tacconelli,et al. Mode of action of aspirin as a chemopreventive agent. , 2013, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[9] S. Tacconelli,et al. Mechanisms of the antitumoural effects of aspirin in the gastrointestinal tract. , 2012, Best practice & research. Clinical gastroenterology.
[10] S. Safe,et al. Inhibition of NFκB and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulation* , 2010, The Journal of Biological Chemistry.
[11] D. Steinhilber,et al. Phytochemicals resveratrol and sulforaphane as potential agents for enhancing the anti-tumor activities of conventional cancer therapies. , 2012, Current pharmaceutical biotechnology.
[12] J. Cuzick,et al. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] E. Ho,et al. Multi-targeted prevention of cancer by sulforaphane. , 2008, Cancer letters.
[14] T. Kensler,et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] Zhiwei Wang,et al. Retracted: Notch‐1 down‐regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells , 2006, Cancer.
[16] Paul Talalay,et al. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. , 2007, Carcinogenesis.
[17] Abhishek Sahu,et al. Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. , 2008, Acta biomaterialia.
[18] S. Hecht,et al. Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. , 2005, Cancer research.
[19] B. Aggarwal,et al. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. , 2008, Biochemical pharmacology.
[20] B. Aggarwal,et al. Curcumin: the Indian solid gold. , 2007, Advances in experimental medicine and biology.
[21] V. Steele,et al. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. , 2000, The Journal of nutrition.
[22] S. Jee,et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.
[23] L. Bergmann,et al. Curcumin Inhibits Constitutive STAT3 Phosphorylation in Human Pancreatic Cancer Cell lines and Downregulation of Survivin/BIRC5 Gene Expression , 2009, Cancer investigation.
[24] Shadan Ali,et al. Fluorocurcumins as Cyclooxygenase-2 Inhibitor: Molecular Docking, Pharmacokinetics and Tissue Distribution in Mice , 2009, Pharmaceutical Research.
[25] S. Batra,et al. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells , 2009, British Journal of Cancer.
[26] F. Ahmad,et al. Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies , 2014, Drug development and industrial pharmacy.
[27] A. Dennison,et al. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration , 2004, British Journal of Cancer.
[28] T. Kensler,et al. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[29] W. Grizzle,et al. Polyethylene Glycosylated Curcumin Conjugate Inhibits Pancreatic Cancer Cell Growth through Inactivation of Jab1 , 2009, Molecular Pharmacology.
[30] Donald J L Jones,et al. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[31] B. Aggarwal,et al. Nuclear factor‐κB and IκB kinase are constitutively active in human pancreatic cells, and their down‐regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis , 2004, Cancer.
[32] P. Rothwell,et al. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials , 2012, The Lancet.
[33] C. Rao,et al. Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. , 2000, Carcinogenesis.